Research Areas

GLP-1, GIP and glucagon agonists (semaglutide, tirzepatide, retatrutide) and amylin analogues (cagrilintide) studied for appetite, glucose handling and body-weight research.

Compounds studied for lipolysis, energy expenditure and metabolic rate (AOD-9604, 5-Amino-1MQ, tesofensine).

Studied for tissue, tendon and gut-lining repair and angiogenesis (BPC-157, TB-500).

GH secretagogues and GHRH analogues studied for the growth-hormone axis, body composition and recovery (CJC-1295, ipamorelin, sermorelin).

Studied for muscular performance, endurance and exercise adaptation (AICAR, follistatin, ACE-031).

Peptides studied for inflammatory-pathway modulation (KPV, ARA-290).

Bioregulators and senescence-related peptides studied in ageing, telomere and cellular-longevity models (epitalon, thymalin).

Peptides studied for mitochondrial function and cellular energy (MOTS-c, SS-31).

Studied for skin regeneration, collagen and dermatological research (GHK-Cu).

Melanocortin-receptor agonists studied for pigmentation and related research (melanotan I/II).

Studied in hair-follicle and hair-growth research (GHK-Cu, PTD-DBM).

Studied for oxidative-stress, glutathione and detoxification pathways (glutathione, NAD+).

Peptides studied for memory, focus and neuroprotection (semax, dihexa).

Studied for anxiolytic and mood-related pathways (selank).

Studied for sleep architecture and circadian research (DSIP).

Studied for libido and sexual-response pathways (PT-141).

Reproductive-axis and hormone-signalling peptides (gonadorelin, kisspeptin, HCG).

Post-cycle-support compounds studied for estrogen and prolactin control in hormonal research.

Peptides studied for immune modulation and host-defence research (thymosin alpha-1, LL-37).

Studied in analgesic and neuropathic-pain research (ARA-290).

Specialist or experimental research tools outside the main areas (cardiovascular, antiparasitic).